Labcorp Holdings Inc.
Business Model Analysis
How Labcorp Makes Money
Annual Revenue: $14.0B
Labcorp generates revenue primarily through Clinical Laboratory Services and Biopharma Laboratory Services, with roughly $14.0B in annual revenue.
Core Growth Engine: Labcorp's stated priorities are leading in specialty testing, being the partner of choice for health systems and regional labs, growing consumer health, and using technology and AI to cut cost. In 2025 it launched more t...
Revenue Model & Pricing
Labcorp makes money in two segments. Diagnostics Laboratories ($10.88 billion of 2025 revenue, about 78%) collects specimens through roughly 2,000 patient service centers, in-office phlebotomists, and courier and aircraft routes, runs routine and specialty tests in automated labs, and bills commercial insurers, Medicare and Medicaid, physicians, hospitals, and consumers. Biopharma Laboratory Services ($3.10 billion, about 22%) earns contract fees from drug, biotech, and device companies for central-laboratory testing in clinical trials and early-development (preclinical) studies; it ended 2025 with an $8.72 billion backlog. Hospital lab management and outreach acquisitions feed additional volume into the diagnostics network.
Core Revenue Streams
Diagnostics Laboratories
~78%Routine and specialty testing ordered by physicians, hospitals, health systems, employers, payers, and patients.
Biopharma Laboratory Services
~22%Central laboratory, early development, companion diagnostics, and clinical-trial laboratory support for pharmaceutical, biotech, medical device, and diagnostic customers.
Health-System Partnerships
Embedded in diagnosticsTransactions and partnerships that shift hospital or regional laboratory testing volume onto Labcorp infrastructure.
Specialty and Esoteric Testing
Embedded in diagnosticsHigher-complexity areas such as oncology, women's health, genetics, neurology, autoimmune disease, and precision medicine.
Growth Strategy
Labcorp's stated priorities are leading in specialty testing, being the partner of choice for health systems and regional labs, growing consumer health, and using technology and AI to cut cost. In 2025 it launched more than 130 new tests and signed or closed 13 health-system and regional lab transactions; 2026 deals include outreach assets from Crouse Health, Parkview Health, and Tribal Diagnostics. The MyLabcorp app and Labcorp OnDemand push direct-to-consumer testing.
How Labcorp Makes Money: FAQ
How does Labcorp Holdings Inc. generate revenue and cash flow?
Labcorp generates revenue primarily by performing clinical diagnostic testing, esoteric genomic assays, and anatomic pathology services, billing commercial health insurance companies, government healthcare programs (Medicare and Medicaid), hospital systems, employers, and patients on a fee-for-service basis.
What are Labcorp's two core operating business segments following the Fortrea spin-off?
Labcorp operates across two primary segments: Diagnostics Laboratories (routine and specialty clinical laboratory testing for physicians, health systems, and consumers) and Central Laboratories / Biopharma Services (providing specialized clinical trial lab testing and safety assays for pharmaceutical drug developers).
How does Labcorp acquire hospital and health system laboratory outreach businesses?
Labcorp partners with major regional health systems to acquire their outpatient laboratory outreach operations and manage on-site hospital inpatient labs, allowing health systems to monetize non-core lab assets while reducing operational testing costs.
What is the commercial role of Labcorp's 2,000+ Patient Service Centers (PSCs)?
Patient Service Centers (PSCs) serve as convenient, localized phlebotomy access points located in medical office buildings, commercial plazas, and retail partnerships (such as Walgreens), where phlebotomists collect blood, urine, and tissue specimens from patients.
How does Labcorp manage its cold-chain specimen logistics network?
Labcorp operates a large, proprietary specimen courier logistics network encompassing thousands of ground courier vehicles, regional dedicated aircraft routes, and temperature-controlled packaging that transports millions of patient specimens daily from clinics to central testing mega-labs.
How does Labcorp monetize direct-to-consumer testing through Labcorp OnDemand?
Labcorp OnDemand allows consumers to purchase physician-approved blood tests directly online without an initial doctor visit (including lipid panels, allergy tests, HbA1c diabetes monitoring, and hormone health), paying out-of-pocket via credit card or HSA/FSA funds.
How does Labcorp collaborate with pharmaceutical companies on Companion Diagnostics (CDx)?
Labcorp partners with global biopharma sponsors to discover, clinically validate, and secure FDA approval for companion diagnostic assays that identify specific genetic mutations (such as EGFR, KRAS, and BRCA), ensuring targeted cancer therapies are prescribed to the right patients.
How does Labcorp manage reimbursement rates with commercial health insurers?
Labcorp negotiates multi-year in-network contracted fee schedules with major national managed care health insurers (UnitedHealthcare, Anthem/Elevance, Aetna/CVS, Cigna), securing broad patient access in exchange for standardized volume-discounted testing rates.
How does Labcorp make money?
Labcorp operates two incredibly massive, highly lucrative divisions. First, "Diagnostics": they run thousands of local clinics where millions of Americans go to get their blood drawn, billing insurance companies massive fees. Second, "Biopharma Laboratory Services": massive pharmaceutical companies pay Labcorp staggering billions to run the highly complex, global clinical trials required to get new drugs approved by the FDA.
Related Monetization Mechanics
Compare revenue streams, unit economics, and business models
Explore Labcorp
Core profile pages, founders and related research hubs for this company.